Filing Details
- Accession Number:
- 0001225208-13-007703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-14 16:26:58
- Reporting Period:
- 2013-03-13
- Filing Date:
- 2013-03-14
- Accepted Time:
- 2013-03-14 16:26:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1490216 | M Francis Cuss | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Svp Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2013-03-13 | 65,000 | $25.73 | 244,922 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2013-03-13 | 19,952 | $17.51 | 264,874 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-03-13 | 69,713 | $38.47 | 195,161 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2013-03-13 | 19,952 | $0.00 | 19,952 | $17.51 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2013-03-13 | 65,000 | $0.00 | 65,000 | $25.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-02 | No | 4 | M | Direct | |
| 0 | 2013-09-30 | No | 4 | M | Direct |
Footnotes
- Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $38.47 to $38.49, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was October 1, 2003.
Billionaire Hedge Funds
